NPC is Going to ISPOR’s 22nd Annual International Meeting – Are You?

ISPOR 22nd Annual International Meeting

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 22nd Annual International Meeting, held May 20-24 in Boston, offers an array of opportunities to learn from experts about the latest topics in health care. The National Pharmaceutical Council (NPC) will be there to lead issue panels and workshops, participate in discussions and present a poster, among other activities. Find out when, where and what NPC’s research team will be speaking about below so you don’t miss us. We hope to see you there!

Join us on Monday, May 22, for IP3: Value Assessment Debate: Pluralistic Approach or Does One Size Fit All? (Room: Sheraton-Liberty) at 11 a.m. NPC Vice President of Research Michael Ciarametaro, MBA, will moderate and provide an overview of how value assessment may be used by decision makers in various contexts, and Schaeffer-NPC Postdoctoral Health Policy Fellow Ilene Hollin, PhD, will present survey findings measuring differences in how stakeholders prioritize value inputs and apply those results to case studies to evaluate the limitations of a singular approach.

Later that day, pencil in W2: Actuarial and Health Economic Approaches to Assess Value: Speaking the Same Language or Need for Translation? (Room: Sheraton-Constitution) from 2:15-3:15 p.m. NPC Vice President of Comparative Effectiveness Research Jennifer Graff, PharmD, will be a discussion leader for the workshop, which will compare and contrast the responsibilities, audiences, methods, data sources, and values used by actuaries and health economists to predict health care costs.

And make sure to save time Monday afternoon for IP6: Is There Consistency in the Evidence that Payers Report Reviewing when Determining Drug Coverage? Should It Be Consistent? (Room: Sheraton-Republic) from 3:45-4:45 p.m. This issue panel, which will provide a forum to discuss private payers’ use of evidence and to debate how evidence should be used to guide coverage of drugs and other technologies, will be moderated by Dr. Graff.

NPC’s analysis of the Affordable Care Act’s risk-adjustment program for the individual insurance marketplaces will also be presented at a poster session on Monday, May 22, between 8:30 a.m. and 2:30 p.m. NPC Research Associate Lisabeth Buelt, MPH, will present NPC’s poster, Will the Revised HHS Risk Adjustment Methodology Improve Accuracy in Predicting Costs for Diseases With Non-uniform Patient Use of Specialty Therapeutics?, at the Hynes Convention Center – Auditorium and Hall C from 1-2 p.m.

On Tuesday, May 23, join us for IP14: Health Care Economic Information: Considerations for Expanding Proactive Communications by Biopharmaceutical Manufacturers to Population Health Decision Makers (Invited Issue Panel) (Room: Sheraton-Constitution) from 3:45-4:45 p.m., which will feature Dr. Graff as a panelist. This panel discussion will provide key stakeholder perspectives on why access to health care economic information is critical to better care for patients and debate possible solutions to enable better and timelier communications between biopharmaceutical manufacturers and population health decision-makers.

Finally, be sure to stop by NPC’s table at the exhibition hall, Booth #411, to meet NPC staff and pick up copies of our latest research.

For more information about the event and to view the full speaker lineups for NPC’s panels, visit NPC’s events page.